Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 2641 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer

Read more ››
By: GlobeNewswire - 01 Apr 2024
Related companies:  Cyclacel Pharmaceuticals, Inc.

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

Read more ››
By: GlobeNewswire - 01 Apr 2024
Related companies:  SOHM Inc

Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024

Read more ››
By: GlobeNewswire - 01 Apr 2024
Related companies:  Mesa Labs, Inc.

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

Read more ››
By: GlobeNewswire - 01 Apr 2024
Related companies:  Eiger BioPharmaceuticals, Inc.

Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement

Read more ››
By: GlobeNewswire - 01 Apr 2024
Related companies:  Applied UV, Inc.

BioSyent to Present at LD Micro New York Investor Conference

Read more ››
By: GlobeNewswire - 01 Apr 2024
Related companies:  BioSyent Inc.

HNL Lab Medicine Unveils Lifesaving Cellular Therapy Laboratory

Read more ››
By: GlobeNewswire - 01 Apr 2024

Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  Inspira Technologies

ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  Vialase, Inc.

SHE'S INDEPENDENT INVESTS IN ASTEK DIAGNOSTICS' PRE-SERIES A ROUND

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024

Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024

Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  Elanco Animal Health

3M Completes Spin-off of Solventum

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  3M Corporation

Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  Viatris Inc.

BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  Bio-Techne Corporation

Carisma Therapeutics Announces Changes to its Board of Directors

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  Carisma Therapeutics Inc.

Lutris Pharma Appoints Life Sciences and Pharmaceutical Entrepreneur Moshe "Mori" Arkin to Its Board of Directors

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024

Ionis to present at upcoming investor conferences

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  Ionis Pharmaceuticals, Inc.

Haemonetics Corporation Completes Acquisition of Attune Medical

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  Haemonetics Corporation

Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

Read more ››
By: PR Newswire Association LLC. - 01 Apr 2024
Related companies:  EpiVax, Inc. | EpiVax Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑